Xiaflex was approved in 2010 for the treatment of Dupuytren’s contracture. Dupuytren’s contracture is a condition where nodules form under the skin in the palm of the hand. These nodules thicken and ...
BioSpecifics Technologies announced that the FDA has accepted for filing and granted priority review of the Biologics License Application (BLA) submitted for Xiaflex. Xiaflex treats Dupuytren’s ...
DUBLIN, June 5, 2023 /PRNewswire/ -- Endo International plc (ENDPQ) announced today that post-hoc data from two Phase 3 studies of XIAFLEX ® (collagenase clostridium histolyticum, or CCH, injection ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results